Atrial fibrillation (AF) is the most common type of sustained cardiac arrhythmia [1]. With the
ever-ageing populations, the prevalence of AF is expected to increase and progress with …

Due in large part to the growing dissatisfaction with traditional pharmacologic approaches to
atrial fibrillation (AF) management, and fueled by both the fruits of basic and clinical …

Background: Ablation for atrial fibrillation (AF) is a widely-accepted treatment for this
arrhythmia. Ablation is traditionally reserved for second-line therapy in patients who have …

Atrial fibrillation (AF) is the most common cardiac arrhythmia encountered in clinical practice,
affecting approximately 3% of the general population. 1 In addition to reductions in quality of …

Atrial fibrillation (AF) is the most common arrhythmia seen in clinical practice, and is
associated with increased morbidity and mortality. Management of AF is challenging due to …

Atrial fibrillation (AF) is a common arrhythmia, affecting an estimated 2 million people in the
United States (Table 1). The data from the Framingham indicate that the prevalence of AF …

The prevalence of atrial fibrillation (AF) has risen significantly over the past two decades.
Catheter ablation is an increasingly utilized treatment strategy and has evolved significantly …

Atrial fibrillation (AF) is the most common arrhythmia and is associated with substantial
morbidity, including heart failure and stroke. w1 AF is often encountered in patients with …

Atrial fibrillation (AF) is the most common cardiac arrhythmia and its prevalence is expected
to increase as our population ages. The medical management of AF has yielded only …

Atrial fibrillation (AF) is one of the most common cardiac arrhythmias. Catheter ablation has
proven more effective than antiarrhythmic drugs in preventing clinical recurrence of AF …